Focus Stocks
Amgen Is Moving Above Resistance
Published on Wednesday, 05 December 2012 06:36 Written by TradersHuddle Wire
New York, December 5th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) closed the session at $88.33 just above calculated resistance at $87.64. The stock effectively broke out and grasped the attention of momentum traders, which could eventually push the stock to a different trading range.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
The stock was trading in a well defined range with support at $82.92 and resistance at $87.64. Given that this range was broken, traders will be closely monitoring Amgen's price action to gather clues on the future direction.
From a technical perspective, it can be expected that previous resistance becomes support, as the new range gets defined. However, given that Amgen is still near the broken resistance level, traders will be focusing on the $87.64 level to see if the stock holds the breakout without rolling over.
Related Articles
- Approaching Support: Amgen
- Is Amgen Close to Support?
- Amgen Is Close to its 200 Day Moving Average
- Amgen Broke Support
- Trading the Setup In Amgen
- Approaching Support: Amgen
- Amgen Is Close to the 50 Day Moving Average
- Trading the Setup In Amgen
- NASDAQ 100 Round Up - Flat: FSLR, CTRP, BIDU
- Reference Points for Amgen
Related Partner Headlines
- Cramer's Top Stock Picks: AMGN, HPY, but Avoid JCP - TheStreet.com
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) - TheStreet.com
- Amgen Inc (AMGN): Today's Featured Drugs Winner - TheStreet.com
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial Did Not Meet Primary Endpoint - Benzinga
- Amgen Inc Stock Buy Recommendation Reiterated (AMGN) - TheStreet.com
- UPDATE: Oppenheimer Raises PT to $89 on Amgen - Benzinga
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Amgen - Benzinga
- Amgen's Third Quarter Earnings Report - Investopedia
- Analysts' Actions: CAT AMGN DNKN BTU COF - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,112.19 Trade time:4:52PM EDT Value change:▼206.04 (-1.35%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,628.93 Trade time:4:52PM EDT Value change:▼22.88 (-1.39%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,443.20 Trade time:5:15PM EDT Value change:0.00 (0.00%)In The Wires
-
The Former Breezes Resort is Re-Opened by Blue Diamond Resorts as the Original Grand Lido Negril Announced Go Classy Tours -
Zac Brown Band Tickets for Raleigh, Columbia, Darien Center, Gilford, Minneapolis, Holmdel, Pittsburgh, Camden, Atlanta, Boston, Bethel, Toronto & Hartford Now Available -
Jake's Fireworks Announces Opening Of New SuperStore - Auburn Hills, Michigan -
The Hidden Cost of Unemployment -
Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine -
LG, Qualcomm Expand Successful Collaboration With Next G Series Smartphone -
Kotel Finance & Services Are Announcing on New Services -
Fun Depot Partners with Brookstone Lodge on Summer Packages








